We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
Cap. Flow
-$1.33B
Cap. Flow %
-3.4%
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110

Top Buys

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$2.28B
2
OTIS icon
Otis Worldwide
OTIS
+$193M
3
BURL icon
Burlington
BURL
+$191M
4
ABBV icon
AbbVie
ABBV
+$178M
5
W icon
Wayfair
W
+$144M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$1.66B
2
LMT icon
Lockheed Martin
LMT
+$339M
3
JNJ icon
Johnson & Johnson
JNJ
+$262M
4
PFE icon
Pfizer
PFE
+$167M
5
TGT icon
Target
TGT
+$141M

Sector Composition

Rank Sector Weight
1 Technology 21.52%
2 Healthcare 19.78%
3 Consumer Discretionary 13.09%
4 Financials 11.33%
5 Industrials 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBC
826
DELISTED
WABCO HOLDINGS INC.
WBC
-20,100
Closed -$2.71M
FTSI
827
DELISTED
FTS International, Inc. Common Stock
FTSI
-3,250
Closed -$14K
AGN
828
DELISTED
Allergan plc
AGN
-9,369,802
Closed -$1.66B
MLNX
829
DELISTED
Mellanox Technologies, Ltd.
MLNX
-240,100
Closed -$29.1M
RTN
830
DELISTED
Raytheon Company
RTN
-818,400
Closed -$107M
PACD
831
DELISTED
Pacific Drilling S.A. Common Shares
PACD
-537,157
Closed -$231K
ZGNX
832
DELISTED
Zogenix, Inc.
ZGNX
-450,000
Closed -$11.1M
HSKA
833
DELISTED
Heska Corp
HSKA
-75,000
Closed -$4.15M

Similar funds

Adage Capital Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.

  • Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
  • Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
  • Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
  • Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
  • Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
  • Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
  • Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.

Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.